Novo Nordisk is a globally recognized Danish company specializing in the treatment of diabetes, growth hormone deficiency, bleeding disorders, and obesity. Founded in 1923 and headquartered in Bagsværd, it is one of the world's largest insulin producers. Known for its groundbreaking research and development, Novo Nordisk continuously improves the quality of life for people with chronic diseases while maintaining a strong commitment to sustainability and social responsibility.
Aircold has delivered advanced cooling solutions to Novo Nordisk, including precision cooling for pharmaceutical storage and various company facilities. Our tailored systems ensure strict temperature control, which is crucial for preserving the quality and effectiveness of medications and other sensitive materials.
Equipped with state-of-the-art technology, our cooling solutions integrate energy-efficient systems that meet stringent reliability and environmental standards. By providing sustainable and high-performance cooling solutions, Aircold supports Novo Nordisk’s ongoing pursuit of innovation and excellence in the pharmaceutical industry.